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Abstract
Our previous results have demonstrated that tyrosine kinase inhibition reduces if in rabbit SA node myocytes, suggesting
that tyrosine kinases regulate if . One receptor tyrosine kinase the EGF receptor kinase is known to increase heart rate. To
determine if this action is mediated through changes in if , we examined the effect of epidermal growth factor (EGF) on if with
the permeabilized patch-clamp technique. 0.1 WM EGF increased if amplitude in response to single-step hyperpolarizations in
the diastolic range of potentials. This increase was 20 þ 3%, n = 11 at 375 mV. This effect is caused by activating a tyrosine
kinase because 50 WM genistein, a tyrosine kinase inhibitor, eliminated this EGF action. A two-step pulse protocol showed
that maximal if conductance was increased by EGF. We further examined this conductance change by constructing the
activation curve. The maximal if conductance was increased by 23% with no change in midpoint, V1=2, control =374 þ 2 mV,
V1=2 EGF =374 þ 1 mV. Thus EGF acts via a tyrosine kinase to increase maximal if conductance with no change in the
voltage dependence of activation. These results suggest that EGF effects on if contribute to the positive chronotropic effect of
EGF on SA node. ß 2000 Published by Elsevier Science B.V. All rights reserved.
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Protein kinases play important roles in intracellu-
lar signalling pathways [1]. Serine/threonine kinases
phosphorylate and modulate transmembrane ionic
channels in heart [1^3]. Recent studies indicate that
tyrosine kinases also play a crucial role in modula-
tion of neurotransmitter receptors and transmem-
brane ionic channels [4]. Although tyrosine kinases
are associated with relatively long-term cellular pro-
cesses like proliferation, di¡erentiation and metabo-
lism [5,6], activation of tyrosine kinases also contrib-
ute to a wide variety of cellular functions [7]
including ion channel modulation [8].
In a previous study [9], we have shown that tyro-
sine kinase inhibition reduces if in rabbit SA node
myocytes. Our results strongly suggest that tyrosine
phosphorylation can be an important component of
if regulation. However, these results did not demon-
strate whether the tyrosine kinase activity is con-
trolled by a ligand which binds to a so-called recep-
tor tyrosine kinase increasing its activity or whether
regulators exist in the cytosol. To attempt to discrim-
inate between these two alternatives, we examined
the e¡ect of epidermal growth factor (EGF) on if .
The reasons we selected EGF for our study were (1)
the EGF receptor is the best understood growth fac-
tor receptor protein tyrosine kinase [7], and (2) EGF
is known to produce positive chronotropic e¡ects in
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cultured ventricular myocytes [10] and in isolated
perfused rat hearts [11].
Isolated rabbit SA node myocytes were prepared
as previously described by standard techniques [12].
Tyrode solution contained (mM): NaCl, 137.7;
NaOH, 2.3; MgCl2, 1; glucose, 10; Hepes, 5; KCl,
5.4; CaCl2, 1.8; MnCl2, 2 and CdCl2, 0.2; pH 7.4.
Pipette solution contained (mM): NaCl, 6; potassi-
um aspartate, 130; MgCl2, 2; CaCl2, 5; EGTA, 11;
Na2-ATP, 2; Na-GTP, 0.1; Hepes, 10; pH 7.2 (ti-
trated with 3 M KOH). The amphotericin B perfo-
rated patch technique was used to prevent ‘rundown’
of if . The pipette was ¢lled with pipette solution
containing amphotericin B (240 Wg/ml) which was
prepared just before the experiments [13]. The pipette
resistance when ¢lled with pipette solution was 6^8
M6. The isolated cells were placed in a temperature-
controlled lucite bath (35 þ 0.5‡C). An Axopatch 1D
ampli¢er was employed.
Epidermal growth factor (EGF) and genistein were
purchased from Sigma Chemical (St. Louis, MO,
USA) and were added to the control solution in
the concentrations indicated below. Genistein was
dissolved in DMSO and diluted 2000 times in Tyrode
solution.
Our previous observations demonstrated that tyro-
sine phosphorylation modulates if [9]. Here we exam-
ine the e¡ect of EGF, which activates the intrinsic
protein tyrosine kinase activity of its receptor [14], on
if current.
Fig. 1 shows records of if in control solution, in
the presence of 0.1 WM EGF and after washout. We
employed a single hyperpolarizing voltage step of 1.5
to 3 s in duration from a holding potential of 335
mV to a maximum of 3125 mV in 10-mV incre-
ments. The increase in if amplitude was observed
about 5^10 min after the addition of 0.1 WM EGF
(Fig. 1B), and this e¡ect was reversible (Fig. 1C). In
a total of 11 experiments EGF increased if by an
average of 20 þ 3% at 375 mV (mean þ S.E.M.).
Fig. 1. The e¡ects of EGF on if in rabbit sinus node myocytes studied with the permeabilized patch technique. The cell was held at
335 mV and hyperpolarized in 10-mV increments to a maximum value of 375 mV. (A) if recorded in control solution; (B) currents
recorded in the presence of 0.1 WM EGF; (C) washout EGF. (D) The I^V relationship for A to C.
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In order to determine whether the increase in if
produced by EGF was due to activation of a tyrosine
kinase, the tyrosine kinase inhibitor, genistein (50
WM), was employed. Fig. 2 provides one example
from these experiments. In the presence of 50 WM
genistein, EGF decreased if at 375 mV by 7 þ 4%
(n = 4). On washout of genistein, if was increased
by 0.1 WM EGF (Fig. 2C). if at 375 mV was
32 þ 1%, n = 3, larger after washout of genistein.
These data suggest that the action of EGF on if
was mediated through the activation of a tyrosine
kinase.
To determine if the increase of if amplitude by
EGF is caused by a change in if conductance (as
indicated by tyrosine kinase inhibition in our pre-
vious study [9]), a two-step pulse protocol was em-
ployed. The holding potential was 335 mV, a ¢rst
hyperpolarizing pulse was applied to 375 mV which
is near the middle of the if activation range, a second
hyperpolarizing pulse was then applied to 3110 mV
near the top of the activation curve. We can see from
Fig. 3 that addition of 0.1 WM EGF increased if in
response to both hyperpolarizing clamp pulses. Sim-
ilar results were observed in a total of ¢ve experi-
ments. These data suggest an increase in maximal if
conductance but do not rule out a concomitant pos-
itive shift of if activation. In order to further inves-
tigate this question we constructed activation curves
for if . We hyperpolarized to various potentials within
the activation range and recorded the tail currents on
return to the holding potential (see Fig. 4). We plot-
ted the amplitude of the tail currents against the test
potential. The results from four cells are shown in
Fig. 4. The control data were normalized to a max-
imal conductance of unity. The data was ¢t to a
Boltzmann two-state model. The half-activation vol-
tages were 374 þ 2 in control and 374 þ 1 in EGF.
The slope factor was 11.2 þ 1.3 mV in control and
10.7 þ 0.7 mV in EGF. The conductance was 1.23
times the control conductance in EGF.
Fig. 2. E¡ect of 0.1 WM EGF on if in the presence of genistein. The holding potential was 335 mV, the voltage steps were 345 mV
to 375 mV in 10-mV increments. (A) In the presence of 50 WM genistein; (B) 0.1 WM EGF plus 50 WM genistein; (C) washout of
genistein with EGF-containing solution. (D) The I^V relationship for A to C.
BBAMEM 70871 27-12-99
J.-Y. Wu et al. / Biochimica et Biophysica Acta 1463 (2000) 15^19 17
We also examined the kinetics of activation in con-
trol and in the presence of EGF at voltages between
365 mV and 3105 mV. No change in the time con-
stant was observed at any test potential consistent
with the absence of a shift in the voltage dependence
of activation.
The present study demonstrates for the ¢rst time
that EGF activates if through a tyrosine kinase in
rabbit SA node myocytes.
The evidence to date strongly suggests that tyro-
sine phosphorylation is an important component of
ion channel modulation [8]. EGF is one of the recep-
tor tyrosine kinases which is known to act by binding
to its receptor and increasing its intrinsic receptor
protein tyrosine kinase activity, resulting in phos-
phorylation of a number of cellular proteins
[7,15,16]. The activity of this receptor tyrosine kinase
can be inhibited by genistein, one of the speci¢c ty-
rosine kinase inhibitors [17].
Several reports have shown that genistein’s ability
to inhibit responses to growth factors correlates with
a decrease in the level of tyrosine phosphorylation
[18]. Our observations indicate that the increase in
amplitude of if induced by EGF requires activation
of its tyrosine kinase because cells pretreated with 50
WM genistein exhibited no if increase on exposure to
EGF. Since EGF binds to its receptor to exert its
biological actions, the tyrosine kinase activated by
EGF is most likely its receptor protein tyrosine ki-
nase. These results are consistent with observations
that EGF produces positive chronotropic e¡ects in
cultured ventricular myocytes (1.6 WM) [10] and in
isolated perfused rat hearts (15 nM) [11] by activat-
ing the EGF receptor tyrosine kinase.
Our results also provide conclusive data indicating
the mechanism of EGF stimulation. Two di¡erent
experimental approaches (construction of activation
curves and the two-pulse protocol) suggested the
same conclusion that the e¡ect of EGF is primarily
on maximal if conductance. These data are consis-
tent with previous work from our laboratory which
demonstrated that tyrosine kinase inhibition reduces
if conductance.
Fig. 3. EGF alters if conductance. A two-step pulse protocol
was used: the holding potential was 335 mV, the ¢rst pulse
was to 375 mV which was near the middle of the if activation
curve, the second pulse was to 3110 mV which was near the
top of the activation curve. (Left) Currents recorded in control
and in solution containing 0.1 WM EGF. (Right) Washout of
EGF resulted in recovery of if near control levels.
Fig. 4. if activation curves in control and in the presence of 0.1
WM EGF. (Upper) if currents were elicited upon hyperpolariza-
tion to various voltages from a holding potential of 335 mV
then followed by deactivating pulses to 335 mV. (Lower) Nor-
malized conductances of control and EGF obtained from the
tail current amplitudes shown in the inset of the upper panel.
The data were ¢t to a Boltzmann two-state model as in [24].
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Recently the molecular correlate of if was identi-
¢ed [19^21]. The family of if ion channel subunits
was called HCN (for hyperpolarization-activated cy-
clic nucleotide gated). There are four members of this
family, three of which are present in SA node [22].
The initial cloning was achieved by homology to src
[23], suggesting the potential importance of tyrosine
phosphorylation. Given our previous study with ty-
rosine kinase inhibition [9] and the present results
with EGF, it is clear that tyrosine kinases regulate
if . However, much remains uncertain about the sec-
ond-messenger pathways involved. The intervening
steps in this regulation remain fruitful areas for fu-
ture investigation.
This work was supported by Grants HL28958 and
HL20558 from the NHLBI.
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